# FDA Inspection 1164613 - Ascension Seton - March 11, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/f0ec74b0-b9c7-4c34-bf69-b3b5de172837
Source feed: FDA_Inspections

> FDA Inspection 1164613 for Ascension Seton on March 11, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164613
- Company Name: Ascension Seton
- Inspection Date: 2022-03-11
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278262 - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/efa05678-5910-4140-b0c6-f80c3e5a1338)
- [FDA Inspection 1278262 - 2025-07-25](https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/c3f19702-ba1d-4b4d-bdd4-0930fce43003)
- [FDA Inspection 1164613 - 2022-03-11](https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/d167d6cb-30c4-4d38-b046-a901b76b6cbe)
- [FDA Inspection 1056476 - 2018-06-08](https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/18570beb-e1cb-41d7-8449-de4e53a8aedc)
- [FDA Inspection 960814 - 2016-01-20](https://www.globalkeysolutions.net/records/fda_inspections/ascension-seton/88cd6ff5-c2ed-41f0-b171-b518ba29d79c)

Company: https://www.globalkeysolutions.net/companies/ascension-seton/db3ad234-11f3-4b16-b488-2fe5d763e99f

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d